Bovine milk-derived exosomes for drug delivery
By Radha Munagala, F. Aqil, J. Jeyabalan, Ramesh C. Gupta. Cancer Letters, 2015
843 citations recorded by the source corpus.
Exosomes are biological nanovesicles that are involved in cell-cell communication via the functionally-active cargo (such as miRNA, mRNA, DNA and proteins). Because of their nanosize, exosomes are explored as nanodevices for the development of new therapeutic applications. However, bulk, safe and cost-effective production of exosomes is not available. Here, we show that bovine milk can serve as a scalable source of exosomes that can act as a carrier for chemotherapeutic/chemopreventive agents. Drug-loaded exosomes showed significantly higher efficacy compared to free drug in cell culture studies and against lung tumor xenografts in vivo. Moreover, tumor targeting ligands such as folate increased cancer-cell targeting of the exosomes resulting in enhanced tumor reduction. Milk exosomes exhibited cross-species tolerance with no adverse immune and inflammatory response. Thus, we show the versatility of milk exosomes with respect to the cargo it can carry and ability to achieve tumor targetability. This is the first report to identify a biocompatible and cost-effective means of exosomes to enhance oral bioavailability, improve efficacy and safety of drugs.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/93909e520611cebf9ee59c999da8f5ea2c09e458
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Precious Akuma
- M. Qasim
- Muniyandi Jeyaraj
- Sangiliyandi Gurunathan
- Chibuike C. Udenigwe
- M. Kang
- Jin-Hoi Kim
- O. Okagu
In Molecular Biology
- Precious Akuma
- M. Qasim
- Muniyandi Jeyaraj
- Sangiliyandi Gurunathan
- Chibuike C. Udenigwe
- M. Kang
- Jin-Hoi Kim
- O. Okagu
Citations in the corpus
- Targeting cancer stem cell pathways for cancer therapy (2020, background): “[544] [545] [546] [547] [548] THERAPEUTIC TARGETING OF CSCS Agents targeting CSC-associated surface biomarkers in clinical trials Monoclonal antibodies (mAbs) that target CSC-specific surface biomarkers have become an emerging technology for cancer therapy.”
- Naturally Occurring Exosome Vesicles as Potential Delivery Vehicle for Bioactive Compounds (2019, background): “Stability of Animal-Derived Exosomes Exosomes are in their optimal state when freshly isolated but can be stored for up to 1 year at −80◦C with no coagulation (Théry et al., 2006; Munagala et al., 2016).”
- Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes (2019, background): “Exosomes loaded with the chemotherapeutic agents, paclitaxel, doxorubicin, and withaferin by passive loading, release these agents slowly and effectively inhibit the proliferation of A549 lung cancer cells in vitro and tumor cells in vivo [287].”
- Plant exosome like nanovesicles: Emerging therapeutics and drug delivery nanoplatforms. (2020, background): “Although this benefits in achieving purity of PELNVs, it drops the PELNV yield concentration.(36,37)”